OncoTherapy Science,Inc. (4564.T) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 5Aug 10Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−6.2x

Market Cap

JPY 7.94B

MomentumView details →

1D Return

+4.76%

YTD Return

+10.00%

RSI (14)

58.9

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−6.2x

Market Cap

JPY 7.94B

RSI (14)

58.9

MomentumView details →

1D Return

+4.76%

YTD Return

+10.00%

ProfitabilityView details →

Gross Margin

3.60%

Net Margin

−112.37%

EBITDA Margin

—

ROE (TTM)

−41.21%

ROA (TTM)

−35.51%

Asset Turnover

0.36x

GrowthView details →

Revenue YoY

+10.89%

EPS YoY

+29.69%

FCF YoY

—

Revenue CAGR 3Y

−13.35%

EPS CAGR 3Y

+48.43%

EBITDA YoY

—

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

—

Current Ratio

8.51x

Quick Ratio

8.43x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

Financials snapshotView financials →

Revenue (TTM)

784.00M

Net Income (TTM)

−881.00M

Op. CF (TTM)

—

Next earningsNov 9, 2026 →

Latest newsMore news →

No recent news for 4564.T.

Similar companies

Kidswell Bio Corporation4584.T Carna Biosciences,Inc.4572.T Tsubota Laboratory Incorporated4890.T Nano Holdings,Inc.4571.T Solasia Pharma K.K.4597.T MORISHITA JINTAN CO.,LTD.4524.T Find similar companies →

Latest newsMore news →

No recent news for 4564.T.